Mechanistically, our study implied that the anti-AD effect of eriodictyol was associated with inhibiting ferroptosis in neural cells through VDR-mediated activation of the Nrf2/HO-1 signaling pathway. Here, HMOX1 is linked to Alzheimer disease.